TRIPTONINE-B;1-BETA,2-BETA,5-ALPHA,8-BETA-TETRA-ACETOXY-3-ALPHA,15-[2'-HYDROXY-2',3'-DIMETHYL-3'-(3''-CARBOXY-4''-PYRIDYL)-PROPANOIC-ACID]-DI-CARBOL
Compound with spectra: 1 NMR
![TRIPTONINE-B;1-BETA,2-BETA,5-ALPHA,8-BETA-TETRA-ACETOXY-3-ALPHA,15-[2'-HYDROXY-2',3'-DIMETHYL-3'-(3''-CARBOXY-4''-PYRIDYL)-PROPANOIC-ACID]-DI-CARBOL](/api/compound/u7Vx0Fu6BI.png?ph=true&h=300&w=458 "TRIPTONINE-B;1-BETA,2-BETA,5-ALPHA,8-BETA-TETRA-ACETOXY-3-ALPHA,15-[2'-HYDROXY-2',3'-DIMETHYL-3'-(3''-CARBOXY-4''-PYRIDYL)-PROPANOIC-ACID]-DI-CARBOL")
| SpectraBase Compound ID | u7Vx0Fu6BI |
|---|---|
| InChI | InChI=1S/C45H55NO22/c1-19-11-12-28(51)26(15-29(52)59-10)38(54)61-18-44-35(64-23(5)49)31(66-37(19)53)30-33(63-22(4)48)45(44)43(9,58)34(32(62-21(3)47)36(44)65-24(6)50)67-40(56)42(8,57)20(2)25-13-14-46-16-27(25)39(55)60-17-41(30,7)68-45/h13-14,16,19-20,26,30-36,57-58H,11-12,15,17-18H2,1-10H3/t19?,20?,26?,30-,31-,32+,33-,34+,35-,36+,41+,42?,43+,44-,45+/m1/s1 |
| InChIKey | GSBZVVMZYQMZBG-XMOOUNKUSA-N |
| Mol Weight | 961.9 g/mol |
| Molecular Formula | C45H55NO22 |
| Exact Mass | 961.321572 g/mol |
| Enantiomer InChIKey | GSBZVVMZYQMZBG-MRQADNDZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
[(3aS,6R,7aR)-Hexahydro-8,8-dimethyl-1-{[(2'R,3S)'-(4"-methoxy-2',3',6'-trimethylphenylsulfonyl)-2'-methylspiro[3H-indle-3,3'-pyrrolidin]-2'-yl}carbonyl-3H,3a,6-methano-2,1-benzisothiazole 2,2-dioxide
(2S,5S,7S,9S,10S,12R,13R*,14R*)-9-[(1S,2R*)-1-Ethyl-2-hydroxybutyl]-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydropyran-2-yl]-15-(4-methoxybenzyloxy)-2,10,12-trimethyl-1,6,8-trioxodispiro[4.1.5.3]pentadecan-13,14-diol
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazacyclohexacosine-32,37,39-trione
(1R,5R,7S,8S,9S,10R)-1-[(2R*,5S)-5-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-9-ethyl-8,10-isopropylidenedioxy-1-(4-methoxybenzyloxy)-5,7-dimethyldodeca-2-yn-4-one
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazcyclohexacosine-32,37,39-trione
(2S,5R,6R,10R,12S,13S,14S,15R)-2-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2,5-bis(tert-butyldimethylsilyloxy)-13,15-isopropylidenedioxy-6-(4-methoxybenzyloxy)-10,12-dimethylheptadec-7-yn-9-one1-yne
| Title | Journal or Book | Year |
|---|---|---|
| Sesquiterpene Alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: A New Class of Potent Anti-HIV Agents | Journal of Natural Products | 2000 |